MRNA vs TENX · rev $145.0M vs P/E 3.4, $24.1M cap
Moderna Inc (MRNA) versus Tenax Therapeutics Inc (TENX) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Tenax Therapeutics Inc (TENX) is a biotechnology company listed on US.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported TENX revenue for 2026-06-30 was $0. Net income was -$33.5M. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
MRNA currently screens at market cap $24.52B. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
Not investment advice. Open the MRNA and TENX stock pages for the full models.
Not investment advice.